VOLUME 4 (2013)
View Archive »
About The Cover
MVP expression in GBM and establishment of stable MVP-overexpressing H7 sublines. Immunofluorescence staining of endogenous MVP (green) in the cytoplasm of MR-1 GBM cells; nuclei (blue) by DAPI; microfilaments (red) by TRITC-phalloidin (bar = 10 µm). See Lötsch et al.
|
|
Table of Contents
Editorial Materials
|
| CDK6 and p16INK4a in lymphoid malignancies |
|
https://doi.org/10.18632/oncotarget.1541
|
| 1858-1859 |
|
| Targeting IL11 signaling in colon cancer |
|
https://doi.org/10.18632/oncotarget.1410
|
| 1860-1861 |
Editorial Broadcast
|
| Mouse models and antiHER2 therapies |
|
https://doi.org/10.18632/oncotarget.1481
|
| 1866-1867 |
Reviews
|
| Computational methods for detecting copy number variations in cancer genome using next generation sequencing: principles and challenges |
|
https://doi.org/10.18632/oncotarget.1537
|
| 1868-1881 |
Research Papers
|
| Increased expression and copy number amplification of LINE1 and SINE B1 retrotransposable elements in murine mammary carcinoma progression |
|
https://doi.org/10.18632/oncotarget.1188
|
| 1882-1893 |
|
| TAp63 regulates oncogenic miR155 to mediate migration and tumour growth |
|
https://doi.org/10.18632/oncotarget.1228
|
| 1894-1903 |
|
| Major vault protein supports glioblastoma survival and migration by upregulating the EGFR/PI3K signalling axis |
|
https://doi.org/10.18632/oncotarget.1264
|
| 1904-1918 |
|
| Identification of novel tumor suppressor proteases by degradome profiling of colorectal carcinomas |
|
https://doi.org/10.18632/oncotarget.1303
|
| 1919-1932 |
|
| HoxA9 regulated Bcl2 expression mediates survival of myeloid progenitors and the severity of HoxA9dependent leukemia |
|
https://doi.org/10.18632/oncotarget.1306
|
| 1933-1947 |
|
| Selective targeting of human colon cancer stemlike cells by the mTOR inhibitor Torin1 |
|
https://doi.org/10.18632/oncotarget.1310
|
| 1948-1962 |
|
| Mode of cell death induced by the HSP90 inhibitor 17AAG tanespimycin is dependent on the expression of proapoptotic BAX |
|
https://doi.org/10.18632/oncotarget.1419
|
| 1963-1975 |
|
| p53 regulates the transcription of the antiinflammatory molecule developmental endothelial locus1 Del1 |
|
https://doi.org/10.18632/oncotarget.1318
|
| 1976-1985 |
|
| Mitochondrial oxidative stress is the achille’s heel of melanoma cells resistant to Brafmutant inhibitor |
|
https://doi.org/10.18632/oncotarget.1420
|
| 1986-1998 |
|
| Chemoresistance to gemcitabine in hepatoma cells induces epithelialmesenchymal transition and involves activation of PDGFD pathway |
|
https://doi.org/10.18632/oncotarget.1471
|
| 1999-2009 |
|
| NFkB disrupts tissue polarity in 3D by preventing integration of microenvironmental signals |
|
https://doi.org/10.18632/oncotarget.1451
|
| 2010-2020 |
|
| FOXD3 is a novel tumor suppressor that affects growth invasion metastasis and angiogenesis of neuroblastoma |
|
https://doi.org/10.18632/oncotarget.1579
|
| 2021-2044 |
|
| 1433σ attenuates RhoGDI2induced cisplatin resistance through activation of Erk and p38 in gastric cancer cells |
|
https://doi.org/10.18632/oncotarget.1334
|
| 2045-2056 |
|
| Induction and transport of Wnt 5a during macrophageinduced malignant invasion is mediated by two types of extracellular vesicles |
|
https://doi.org/10.18632/oncotarget.1336
|
| 2057-2066 |
|
| Alterations of immune response of nonsmall cell lung cancer with Azacytidine |
|
https://doi.org/10.18632/oncotarget.1542
|
| 2067-2079 |
|
| BET bromodomain protein inhibition is a therapeutic option for medulloblastoma |
|
https://doi.org/10.18632/oncotarget.1534
|
| 2080-2095 |
|
| ICRAC controls the rapid androgen response in human primary prostate epithelial cells and is altered in prostate cancer |
|
https://doi.org/10.18632/oncotarget.1483
|
| 2096-2107 |
|
| Bone marrow adipocytes promote tumor growth in bone via FABP4dependent mechanisms |
|
https://doi.org/10.18632/oncotarget.1482
|
| 2108-2123 |
|
| 6p223 amplification as a biomarker and potential therapeutic target of advanced stage bladder cancer |
|
https://doi.org/10.18632/oncotarget.1485
|
| 2124-2134 |
|
| Aberrant chimeric RNA GOLM1MAK10 encoding a secreted fusion protein as a molecular signature for human esophageal squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.1465
|
| 2135-2143 |
|
| KMT2D maintains neoplastic cell proliferation and global histone H3 lysine 4 monomethylation |
|
https://doi.org/10.18632/oncotarget.1555
|
| 2144-2153 |
|
| Aberrantly hypermethylated Homeobox A2 derepresses metalloproteinase9 through TBP and promotes invasion in Nasopharyngeal carcinoma |
|
https://doi.org/10.18632/oncotarget.1367
|
| 2154-2165 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
